Nous contacter

MedinCell annonce le transfert de ses titres du compartiment C au compartiment B d’Euronext Paris

28 janvier 2021

Strengthening of MEDCL stock’s visibility within the financial community
The transfer of MedinCell shares from compartment C to compartment B of Euronext Paris will occur on January 29, 2021.

Compartment B includes issuers with a market capitalisation of between €150 million and €1 billion (included).

Changes of compartment are carried out once a year. Euronext calculates the market capitalisation on the basis of the opening price of the last 60 trading days of the previous year.

The switch to the next compartment up is an important step that underlines the significant increase in MedinCell’s market value in 2020. This change of compartment will help enhance the Company’s visibility within the financial community in France and abroad.

Session en français

Rendez-vous le lundi 14 novembre à 18h00 (CET) pour une vidéoconférence dédiée aux récentes avancées des produits de notre portfeuille clinique

English session

On Monday 14, November at 6.00 pm (CET) participate in our videoconference dedicated to the latest news regarding our clinical and regulatory products

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.

CONTACT

  • Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.